A groundbreaking in vivo clinical study conducted by Dr. Richard Horowitz has found that an eight-week course of the leprosy drug dapsone combined with doxycycline and rifampin is effective in improving symptoms in 98% of patients suffering from chronic Lyme disease/Post... Read More »




























